Bristol-Myers Squibb CompanyBMYNYSE
Loading
Cash Flow PerformanceElevated
Percentile Rank79
3Y CAGR+14.4%
5Y CAGR+4.2%
Year-over-Year Change
Free cash flow yield
3Y CAGR
+14.4%/yr
vs +2.0%/yr prior
5Y CAGR
+4.2%/yr
Recent acceleration
Acceleration
+12.4pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 11.67% | -4.1% |
| 2024 | 12.16% | +2.0% |
| 2023 | 11.92% | +52.9% |
| 2022 | 7.80% | -29.1% |
| 2021 | 11.00% | +15.9% |
| 2020 | 9.49% | +40.9% |
| 2019 | 6.74% | -6.5% |
| 2018 | 7.20% | +72.1% |
| 2017 | 4.19% | +121.8% |
| 2016 | 1.89% | - |